Primary Biliary Cirrhosis: Overlaps with Other Autoimmune Disorders

Abstract

In this article, the authors use the term “overlaps” to refer to the coexistence of primary biliary cirrhosis (PBC) with another autoimmune condition that involves the liver or extrahepatic organs. Diagnosing PBC-autoimmune hepatitis (PBC-AIH) overlap syndrome remains a challenge, especially because there is still no consensus on the most appropriate diagnostic criteria. The prevalence of this condition varies considerably among series of PBC patients, and its treatment demands a combination of ursodeoxycholic acid and immunosuppressive drugs. Overlap syndrome between PBC and primary sclerosing cholangitis is described in exceptional cases. About one in three PBC patients have a concomitant extrahepatic autoimmune disease, which may include rheumatological, endocrinological, gastrointestinal, pulmonary, or dermatological conditions. Overlaps raise several questions, about whether they share much the same genetic susceptibility, as is generally assumed. The pathogenesis of these conditions includes the production of both innate and adaptive immune responses targeting cholangiocytes as well as different extrahepatic tissues. In this sense, overlaps in PBC represent a continuous spectrum of autoimmunity involving liver and extrahepatic tissues.

Keywords

primary biliary cirrhosis - autoimmune hepatitis - overlap syndrome - Sjögren syndrome - Hashimoto thyroiditis

• References

• 1 Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. International Autoimmune Hepatitis Group. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54 (2) 374-385
• 2 Trivedi PJ, Hirschfield GM. Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther 2012; 36 (6) 517-533
• 3 Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28 (2) 296-301
• 4 Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006; 44 (2) 400-406
• 5 Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2010; 8 (6) 530-534
• 6 Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998; 28 (2) 360-365
• 7 Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008; 48 (5) 1540-1548
• 8 Neuhauser M, Bjornsson E, Treeprasertsuk S , et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010; 105 (2) 345-353
• 9 Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 2002; 97 (5) 1191-1197
• 10 Floreani A, Baragiotta A, Guido M. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment. Dig Liver Dis 2003; 35 (2) 128-129
• 11 Suzuki Y, Arase Y, Ikeda K , et al. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. J Gastroenterol Hepatol 2004; 19 (6) 699-706
• 12 Poupon R, Chazouilleres O, Corpechot C, Chrétien Y. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 2006; 44 (1) 85-90
• 13 Gossard AA, Lindor KD. Development of autoimmune hepatitis in primary biliary cirrhosis. Liver Int 2007; 27 (8) 1086-1090
• 14 Tanaka A, Harada K, Ebinuma H , et al. Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome: a rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res 2011; 41 (9) 877-886
• 15 Bonder A, Retana A, Winston DM, Leung J, Kaplan MM. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2011; 9 (7) 609-612
• 16 Yokokawa J, Saito H, Kanno Y , et al. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol 2010; 25 (2) 376-382
• 17 Wang Q, Selmi C, Zhou X , et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 2013; 41: 140-145
• 18 Yoshioka Y, Taniai M, Hashimoto E, Haruta I, Shiratori K. Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy. Hepatol Res 2013;
• 19 Hennes EM, Zeniya M, Czaja AJ , et al; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48 (1) 169-176
• 20 Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18 (4) 998-1005
• 21 Alvarez F, Berg PA, Bianchi FB , et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31 (5) 929-938
• 22 Muratori P, Granito A, Pappas G , et al. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2009; 104 (6) 1420-1425
• 23 Donaldson P, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver disease. Hepatology 1994; 20 (1 Pt 1) 225-239
• 24 Lohse AW, zumBüschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999; 29 (4) 1078-1084
• 25 CossAdame E, Granados J, Uribe M, Torre A. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?. Ann Hepatol 2011; 10 (1) 28-32
• 26 EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51 (2) 237-267
• 27 Joshi S, Cauch-Dudek K, Wanless IR , et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 2002; 35 (2) 409-413
• 28 Silveira MG, Talwalkar JA, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 2007; 102 (6) 1244-1250
• 29 Jung HE, Jang JY, Jeong SW , et al. Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score. Clin Mol Hepatol 2012; 18 (4) 375-382
• 30 Rubel LR, Seeff LB, Patel V. Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome. Arch Pathol Lab Med 1984; 108 (5) 360-361
• 31 Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases. Dig Dis Sci 2001; 46 (9) 2043-2047
• 32 Kingham JGC, Abbasi A. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective. Eur J Gastroenterol Hepatol 2005; 17 (10) 1077-1080
• 33 Jeevagan A. Overlap of primary biliary cirrhosis and primary sclerosing cholangitis - a rare coincidence or a new syndrome. Int J Gen Med 2010; 3: 143-146
• 34 Oliveira EM, Oliveira PM, Becker V , et al. Overlapping of primary biliary cirrhosis and small duct primary sclerosing cholangitis: first case report. J Clin Med Res 2012; 4 (6) 429-433
• 35 Teufel A, Weinmann A, Kahaly GJ , et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010; 44 (3) 208-213
• 36 Floreani A, Caroli D, Variola A , et al. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 2011; 31 (3) 361-368
• 37 Tsianos EV, Hoofnagle JH, Fox PC , et al. Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology 1990; 11 (5) 730-734
• 38 Alarcón-Segovia D, Díaz-Jouanen E, Fishbein E. Features of Sjögren's syndrome in primary biliary cirrhosis. Ann Intern Med 1973; 79 (1) 31-36
• 39 Golding PL, Brown R, Mason AM, Taylor E. Sicca complex” in liver disease. BMJ 1970; 4 (5731) 340-342
• 40 Crowe JP, Christensen E, Butler J , et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 1980; 78 (6) 1437-1441
• 41 Wang L, Zhang F-C, Chen H , et al. Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol 2013; 19 (31) 5131-5137
• 42 Strand V, Talal N. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1979; -1980 30 (9) 1046-1052
• 43 Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994; 72 (2) 162-165
• 44 Fox RI. Sjögren's syndrome. Lancet 2005; 366 (9482) 321-331
• 45 Hernández-Molina G, Leal-Alegre G, Michel-Peregrina M. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome. Autoimmun Rev 2011; 10 (3) 123-125
• 46 Selmi C, Meroni PL, Gershwin ME. Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis. J Autoimmun 2012; 39 (1-2) 34-42
• 47 Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004; 63 (2) 123-129
• 48 O'Brien ST, Eddy WM, Krawitt EL. Primary biliary cirrhosis associated with scleroderma. Gastroenterology 1972; 62 (1) 118-121
• 49 Powell FC, Schroeter AL, Dickson ER. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 1987; 62 (237) 75-82
• 50 Metcalf J, James O. Vascular and autoimmune disease “associations” with PBC. The best evidence available. Hepatology 1996; 24: A168 (Abstr)
• 51 Rigamonti C, Shand LM, Feudjo M , et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 2006; 55 (3) 388-394
• 52 Shoji I, Takagi T, Kasukawa R. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis. Intern Med 1992; 31 (12) 1348-1355
• 53 Cavazzana I, Ceribelli A, Taraborelli M , et al. Primary biliary cirrhosis-related autoantibodies in a large cohort of Italian patients with systemic sclerosis. J Rheumatol 2011; 38 (10) 2180-2185
• 54 Assassi S, Fritzler MJ, Arnett FC , et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009; 36 (10) 2250-2256
• 55 Lurie B, Novis B, Bank S, Silber W, Botha JBC, Marks IN. CRST syndrome and nodular transformation of the liver. A case report. Gastroenterology 1973; 64 (3) 457-461
• 56 McMahon RFT, Babbs C, Warnes TW. Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome? . Gut 1989; 30 (10) 1430-1433
• 57 Inoue K, Hirohara J, Nakano T , et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995; 15 (2) 70-77
• 58 Marasini B, Gagetta M, Rossi V, Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001; 60 (11) 1046-1049
• 59 Datta A, Deodhar SD, Datta U, Sehgal S. Non-organ specific & organ specific antibodies in rheumatoid arthritis. Indian J Med Res 1990; 92: 228-232
• 60 Ruderiman EM. Crawford, Maier A, Liu JJ, Gravallese EM, Weinblatt ME. Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis. Br J Rheumatol 1997; 36: 210-213
• 61 Gershwin ME, Selmi C, Worman HJ , et al; USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005; 42 (5) 1194-1202
• 62 Corpechot C, Chrétien Y, Chazouillères O, Poupon R. Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 2010; 53 (1) 162-169
• 63 Lindor KD, Dickson ER, Jorgensen RA , et al. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. Hepatology 1995; 22 (4 Pt 1) 1158-1162
• 64 Bach N, Bodian C, Bodenheimer H , et al. Methotrexate therapy for primary biliary cirrhosis. Am J Gastroenterol 2003; 98 (1) 187-193
• 65 Kaplan MM, Cheng S, Price LL, Bonis PA. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Hepatology 2004; 39 (4) 915-923
• 66 Modi S, Soejima M, Levesque MC. The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses. Clin Exp Immunol 2013; 173 (1) 8-17
• 67 Spadaro A, Scrivo R, Riccieri V, Valesini G. Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 2008; 75 (1) 87-89
• 68 Kubo S, Iwata S, Saito K, Tanaka Y. Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis. Joint Bone Spine 2011; 78 (5) 535-536
• 69 Liu X, Invernizzi P, Lu Y , et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010; 42 (8) 658-660
• 70 Kar SP, Seldin MF, Chen W , et al; Italian PBC Genetics Study Group. Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. Genes Immun 2013; 14 (3) 179-186
• 71 Mells GF, Kaser A, Karlsen TH. Novel insights into autoimmune liver diseases provided by genome-wide association studies. J Autoimmun 2013; 46: 41-54
• 72 Smyk DS, Bogdanos DP, Mytilinaion MG, Burroughs AK, Rigopoulou EI. Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence or coincidence?. Arthritis 2012; ; ID 391567
• 73 Clark P, Hamilton E, Williams R. Polymyalgia rheumatic and primary biliary cirrhosis. BMJ 1979; 1: 125-126
• 74 Gagnerie F, Taillan B, Engler-Ziegler I, Ziegler G. Primary biliary cirrhosis, temporal arteritis (giant cell arteritis) and polymyalgia rheumatica in a single patient. Scand J Rheumatol 1988; 17 (3) 231-232
• 75 Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet 1959; 1 (7063) 65-69
• 76 Runyon RA, Labreque DR, Asuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histopathologically-proved cases and review of the literature. Am J Med 1980; 69 (2) 187-194
• 77 Matsumoto T, Kobayashi S, Shimizu H , et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000; 20 (5) 366-373
• 78 Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol 2008; 35 (11) 2159-2164
• 79 González LA, Orrego M, Ramírez LA, Vásquez G. Primary biliary cirrhosis/autoimmune hepatitis overlap syndrome developing in a patient with systemic lupus erythematosus: a case report and review of the literature. Lupus 2011; 20 (1) 108-111
• 80 Efe C, Ozaslan E, Nasiroglu N, Tunca H, Purnak T, Altiparmak E. The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases cases: report of three cases and review of the literature. Dig Dis Sci 2010; 55 (8) 2417-2421
• 81 Efe C, Purnak T, Ozaslan E, Ozbalkan Z. The importance of autoimmune hepatitis and primary biliary cirrhosis in patients with systemic lupus erythematosus. Lupus 2011; 20 (1) 112 (letter)
• 82 Heathcote J. The clinical expression of primary biliary cirrhosis. Semin Liver Dis 1997; 17 (1) 23-33
• 83 Logan RF, Ferguson A, Finlayson ND, Weir DG. Primary biliary cirrhosis and coeliac disease: an association?. Lancet 1978; 1 (8058) 230-233
• 84 Sorensen HT, Thulstrup AM, Blomqvist P, Nørgaard B, Fonager K, Ekbom A. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999; 44 (5) 736-738
• 85 Kingham JGC, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998; 42 (1) 120-122
• 86 Habior A, Lewartowska A, Orlowska J, Zych W, Sandowska M, Bauer A , et al. Association of coeliac disease with primary biliary cirrhosis in Poland. Eur J Gastroenterol Hepatol 2003; 15 (2) 159-164
• 87 Lawson A, West J, Aithal GP, Logan RFA. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther 2005; 21 (4) 401-405
• 88 Bizzaro N, Villalta D, Tonutti E , et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci 2003; 48 (12) 2360-2365
• 89 Epstein O, Thomas HC, Sherlock S. Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1980; 1 (8179) 1166-1168
• 90 Arai O, Ikeda H, Mouri H, Notohara K, Matsueda K. Two cases of inflammatory bowel disease diagnosed in the course of primary biliary cirrhosis. Nippon Shokakibyo Gakkai Zasshi 2010; 107 (6) 900-908
• 91 Neuberger J, Primary biliary cirrhosis: associated medical conditions. In: Neuberger J. , ed. Primary Biliary Cirrhosis. Eastbourne, UK: West End Studios Ltd; 1999: 83-91